AETC National Resource Center Biweekly Update: May 8, 2009

Home > News & Events > Biweekly Updates > AETC National Resource Center Biweekly Update: May 8, 2009

AETC National Resource Center Biweekly Update: May 8, 2009

Date: 05/08/2009

New and Updated Resources

HIV Meds Quarterly: Spring 2009
Source: AETC National Resource Center
Date: 05/2009
HIV Meds Quarterly provides brief updates and analysis of new findings related to common therapies used by HIV clinicians.


	Research Briefs: Rosiglitazone and Heart Disease; Antipsychotics and Sudden Cardiac Death; New Pharmacokinetic Booster on the Horizon; Interleukin-2: No Clinical Benefit; Raltegravir Substitution for Lopinavir/Ritonavir (SWITCHMRK Study); Abacavir and Myocardial Infarction Risk: Additional Data

	Reference Table: Updates to the Database of ARV Drug Interactions

	Fast Takes: Darunavir: Traditional approval

	Guidelines: New Guidelines: Adult OI prevention and treatment; Updated: Pediatric ARV guidelines; Updated: Perinatal guidelines

Perinatal Guidelines: Updated Guidelines for Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States
Date: 04/2009
Source: Department of Health and Human Services
Note: This version includes updated references and table of research findings. The recommendation against breastfeeding for HIV-infected women in the U.S. is reiterated.

Perinatal Guidelines Slide Sets
Date: 04/2009
Source: AETC National Resource Center
Note: This slide presentation was developed to accompany the April 2009 version of the perinatal guidelines. Topics include: lessons from clinical trials, preconception counseling and care, management of pregnant women with an HIV-infected male partner, antepartum management, intrapartum management, postpartum management, and neonatal postnatal care.

Chart Links HAB's Performance Indicators to AETC Resources
Source: AETC National Resource Center
Date: 04/30/2009
Note: AETC National Resource Center has developed a webpage chart outlining AETC resources that relate to HAB's clinical performance indicators for Ryan White HIV/AIDS Program-funded clinics. The chart is designed to provide a starting point for faculty developing trainings around these indicators. See HAB's performance indicators at: http://hab.hrsa.gov/special/habmeasures.htm.

Conferences/Trainings

National Minority AETC's Upcoming Conferences

Note: NMAETC is holding a series of trainings in the month of May, such as:


	AI BESAFE Cultural Competency Training--May 8th

	Dental Preceptorship Training- May 11th

	Guarding against Occupational Infections in the HIV Workplace--May 12th

	Improving Communication for Care: Cross Cultural HIV Clinical Settings--May 13th

	Complimentary and Alternative Medicine in AIDS Patients--May 19th

For the complete list of scheduled trainings and additional information, please visit their website: www.nmaetc.org

HIV and Violence against Women Conference

Date: Saturday, August 22nd, 2009
Location: Atlanta, Georgia
Time: 9am - 5pm

Note: One-day conference to enhance understanding of how women's health and wellbeing are influenced by two highly-stigmatized and gendered national issues, HIV and violence against women. Intended for health care and service providers, researchers, advocates, community educators, and policy makers.

Awareness Days

	HIV Vaccine Awareness Day: May 18th Note: Despite much research, there still is not a vaccine for HIV/AIDS. All Americans, especially communities of color and men who have sex with men, need to learn more about HIV vaccine research in order to make an HIV vaccine a reality.

	National Asian & Pacific Islander HIV/AIDS Awareness Day: May 19th Note: According to the CDC, the number of APIs living with AIDS has climbed by more than 10 percent in each of the last 5 years. Sixty-seven percent of API men living with HIV/AIDS in 2005 are men who have had sex with other men. Eighty percent of API women living with HIV/AIDS in 2005 were infected through heterosexual contact.

Others

Special Announcement: CDC Interim Guidance for HIV and Swine Flu

CDC has released interim guidance on H1N1 influenza virus in HIV-infected individuals. To summarize, patients with HIV are at higher risk for more severe influenza and should be treated as high-risk individuals. There is no absolute contraindications for co-administration of oseltamivir or zanamivir, the two drugs recommended to be used for prevention and treatment of H1N1, with currently available antiretroviral medications.

Copyright 2010, the AIDS Education & Training Centers National Resource Center, unless otherwise noted. All rights reserved. Email webmaster@aidsetc.org with questions, comments, or problems. See disclaimer for usage guidelines.